Successful Treatment of Transplant Renal Artery Thrombosis With Systemic Infusion of Recombinant-Tissue-Plasminogen Activator After Renal Transplant

Exp Clin Transplant. 2017 Oct;15(5):571-573. doi: 10.6002/ect.2015.0099. Epub 2015 Aug 31.

Abstract

A 24-year-old man with end-stage renal disease secondary to congenital renal hypoplasia under-went a preemptive renal transplant. Although a vascular complication occurred during surgery, the operation was completed satisfactorily. However, postoperative Doppler ultrasound showed no perfusion of the renal artery, vein, and parenchyma, indicating a transplant renal artery thrombosis. A reoperation was promptly performed, with systemic infusion of recombinant-tissue-plasminogen activator during graft nephrectomy, followed by a reimplant that resulted in a salvage allograft. Immediate thrombolysis using systemically infused recombinant-tissue-plasminogen activator may be an effective treatment option for transplant renal artery thrombosis after renal transplant.

Publication types

  • Case Reports

MeSH terms

  • Fibrinolytic Agents / administration & dosage*
  • Humans
  • Infusions, Intra-Arterial
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / adverse effects*
  • Male
  • Recombinant Proteins / administration & dosage
  • Renal Artery Obstruction / diagnostic imaging
  • Renal Artery Obstruction / drug therapy*
  • Renal Artery Obstruction / etiology
  • Thrombolytic Therapy / methods*
  • Thrombosis / diagnostic imaging
  • Thrombosis / drug therapy*
  • Thrombosis / etiology
  • Tissue Plasminogen Activator / administration & dosage*
  • Treatment Outcome
  • Ultrasonography, Doppler, Color
  • Young Adult

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator